Patents by Inventor Claude Mawas

Claude Mawas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030113322
    Abstract: An isolated CDR-derived polypeptide from monoclonal antibody 13B8.2, a pharmaceutical composition including a pharmaceutically acceptable carrier and at least a peptide, and a method for treating a subject suffering from an autoimmune disorder, including administering to the subject a therapeutically effective amount of a pharmaceutical composition, a method for treating a subject suffering from a transplant rejection including administering to the subject a therapeutically effective amount of a pharmaceutical composition, a method for treating a subject suffering from an HIV immunodeficiency disorder including administering to the subject a therapeutically effective amount of a pharmaceutical composition and a method for treating a subject suffering from a tumoral disorder including administering to the subject a therapeutically effective amount of a pharmaceutical composition.
    Type: Application
    Filed: December 18, 2002
    Publication date: June 19, 2003
    Inventors: Cedric Bes, Laurence Briant-Longuet, Martine Cerutti, Thierry Chardes, Gerard DeVauchelle, Christian DeVaux, Claude Granier, Claude Mawas, Daniel Olive, Bernard Pau
  • Patent number: 5762933
    Abstract: The invention relates to a method for preventing and treating graft failure in humans comprising injecting a specific anti-LFA-1 monoclonal antibody.
    Type: Grant
    Filed: October 17, 1994
    Date of Patent: June 9, 1998
    Assignee: Institut National de la Sante et de la Recherche Medicale
    Inventors: Claude Mawas, Daniel Olive, Alain Fischer, Claude Griscelli